XML 45 R36.htm IDEA: XBRL DOCUMENT
v3.26.1

Segment Reporting (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2026
Segment Reporting [Abstract] |
Schedule of Reconciliation of Condensed Consolidated Operating Expenses and Loss | A reconciliation to condensed consolidated operating expenses as our single segment operating loss for the three months ended March 31, 2026 and 2025, is included in the table below:
|  | Three Months Ended March 31, |
|  | 2026 |  |  | 2025 |
Direct research and development expenses |  |  |  |  |  |
Research and development salaries and benefits |  | $ | 3,769,049 |  |  | $ | 2,651,894 |
Clinical trial expense |  |  | 3,196,835 |  |  |  | 1,927,208 |
Lab supplies and animal care |  |  | 1,094,645 |  |  |  | 556,421 |
Lab services, consulting, and other direct research costs |  |  | 1,002,618 |  |  |  | 942,704 |
Total direct research and development expenses |  |  | 9,063,147 |  |  |  | 6,078,227 |
Indirect research and development expenses |  |  | 1,472,920 |  |  |  | 1,246,805 |
Share based compensation (research and development) |  |  | 2,861,910 |  |  |  | 332,289 |
Total research and development expense |  |  | 13,397,977 |  |  |  | 7,657,321 |
General and administrative expense |  |  |  |  |  |
Administrative payroll |  |  | 1,818,302 |  |  |  | 1,352,628 |
Professional fees and travel |  |  | 717,451 |  |  |  | 425,638 |
Insurance, office expense, and other administrative expenses |  |  | 1,466,004 |  |  |  | 1,055,853 |
Share based compensation (general and administrative) |  |  | 2,598,002 |  |  |  | 280,662 |
Total general and administrative expenses |  |  | 6,599,759 |  |  |  | 3,114,781 |
Total operating expense |  | $ | 19,997,736 |  |  | $ | 10,772,102 |

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration